622
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of stable nanovesicular carrier for drug delivery

, , , &
Pages 296-301 | Received 16 May 2013, Accepted 18 Jun 2013, Published online: 19 Jul 2013

References

  • Alam MN, Ahmad F J, Sultana Y, Iqbal Z, Aqil M, Ali A. 2008. Development and characterization of liposome based formulation of amiloride hydrochloride. J Dispersion Sci Technol. 29:415–420.
  • An K, Sun Y, Xu L, Cui X. 2011. Preparation and in vitro evaluation of simvastatin ethosome. Artif Cells Blood Substit Immobil Biotechnol. 39:347–350.
  • Arifin DR, Palmer AF. 2005. Stability of liposome encapsulated hemoglobin dispersions. Artif Cells Blood Substit Immobil Biotechnol. 33:113–136.
  • Baillie A, Florence A, Hume L, Muirhead G, Rogerson A. 1985. Preparation and properties of niosomes-nonionic surfactant vesicles. J Pharm Pharmacol. 37:863–868.
  • Baydoun L, Muller-Goymann CC. 2003. Influence of n-octenylsuccinate starch on in vitro permeation of sodium diclofenac across excised porcine cornea in comparison to Voltaren ophthalmic gel. Eur J Pharmaceut Biopharm. 56:73–79.
  • Blume G, Cevc G. 1992. Drug-carrier and stability properties of the long-lived lipid vesicles, cryptosomes, in-vitro and in-vivo. J Liposome Research. 2:355–368.
  • Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. 2008. Temoporfin-loaded invasomes: development, characterization and in vitro skin permeation studies. J Control Rel. 127:59–69.
  • Gaur PK, Mishra S, Gupta VB, Rathod MS, Purohit S, Savla BA. 2010. Targeted drug delivery of rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome. Drug Dev Ind Pharm. 36:638–646.
  • Gaur PK, Mishra S, Kumar A, Panda BP. 2014a. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box-Behnken design. Artif Cells Nanomed Biotechnol. 42:167–177.
  • Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A. 2014b. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery. Pharmaceut Dev Tech. 19:48–54.
  • Goñi FM, Alonso A. 2006. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim Biophys Acta. 1758:1902–1921.
  • Ishida T, Takanashi Y, Doi H, Yamamoto I, Kiwada H. 2002. Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes. Int J Pharm. 232:59–67.
  • Kostarelos K. 2003. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv Colloid Interface Sci. 106:147–168.
  • Li X, Ji J, Wang X, Wang Y, Shen J. 2007. Stability and drug loading of spontaneous vesicles of comb-Like PEG derivates. Macromolecul Rapid Comm. 28:660–665.
  • Lintner K, Mondon P, Girard F, Gibaud C. 1997. The effect of a synthetic ceramide-2 on transepidermal water loss after stripping or sodium lauryl sulfate treatment: an in vivo study. Int J Cosmetic Sci. 19:15–26.
  • Liu D, Jiang S, Shen H, Qin S, Liu J, Zhang Q. 2011. Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method. J Nanopart Res. 13:2375–2386.
  • Moore DJ, Rerek ME. 2000. Insights into the molecular organization of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. Acta Dermatologica Venereol Supp. 208:16–22.
  • Nasr M, Mansour S, Mortada ND, Elshamy AA. 2008. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencap. 25:499–512.
  • Sinico C, Manconi M, Valenti M, Fadda AM. 2005. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Rel. 103: 123–136.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin permeation properties. J Control Rel. 65:403–418.
  • Walters KA, Roberts MS. 2002. The structure and function of skin. In: Walters KA, Ed. Transdermal and Dermatological Formulations. New York: Marcel Dekker INC, pp. 1–41.
  • Wartewig S, Neubert RHH. 2007. Properties of ceramides and their impact on the stratum corneum structure: a review. Skin Pharmacol Physiol. 20:220–229.
  • Weber TM, Kausch M, Rippke F, Schoelermann AM, Filbry AW. 2012. Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide. J Clin Aesthet Dermatol. 5:29–39.
  • Wertz PW, Abraham W, Landmann L, Downing DT. 1986. Preparation of liposomes from stratum corneum lipids. J Inves Dermatol. 87:582–584.
  • Yadav AV, Murthy MS, Shete AS, Sakhare S. 2011. Stability aspects of liposomes. Ind J Pharm Edu Res. 45:402–413.
  • Yardley HL, Summerly R. 1981. Lipid composition and metabolism in normal and diseased epidermis. Pharmacol Ther. 13:357–383.
  • Zheng S, Zheng Y, Beissinger RL, Fresco R. 1992. Liposome-encapsulated hemoglobin processing methods. Biomater Artif Cells Immobilization Biotechnol. 20:355–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.